Capricor Therapeutics
CAPR
#5414
Rank
S$1.98 B
Marketcap
S$34.29
Share price
-12.76%
Change (1 day)
167.56%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of March 2026 : S$19.11 Million

According to Capricor Therapeutics 's latest financial reports the company's total debt is S$19.11 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2024-12-31S$1.97 M-33.2%
2023-12-31S$2.95 M-13.96%
2022-12-31S$3.43 M-11.55%
2021-12-31S$3.88 M821.92%
2020-12-31S$0.42 M
2017-12-31N/A-100%
2016-12-31S$20.12 M55.4%
2015-12-31S$12.95 M7.05%
2014-12-31S$12.09 M141.02%
2013-12-31S$5.01 M
2006-12-31S$0.19 M65.47%
2005-12-31S$0.11 M36.28%
2004-12-31S$0.08 M35.08%
2003-12-31S$0.06 M372.55%
2002-12-31S$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$71.10 B 371,818.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.52 B 2,647.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$1.66 B 8,616.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$2.46 M-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$0.17 M-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$0.71 M-96.27%๐Ÿ‡บ๐Ÿ‡ธ USA